Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €0.48 EUR
Change Today +0.018 / 3.88%
Volume 472.8K
ECR On Other Exchanges
As of 12:38 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

ercros sa (ECR) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/27/14 - €0.53
52 Week Low
12/31/14 - €0.38
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for ERCROS SA (ECR)

Related News

No related news articles were found.

ercros sa (ECR) Related Businessweek News

No Related Businessweek News Found

ercros sa (ECR) Details

Ercros, S.A. manufactures and markets basic and intermediate chemicals, plastics, and pharmaceuticals primarily in Spain. Its Basic Chemicals division offers ammonia, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, hydrochloric acid, hydrogen peroxide, potassium carbonate, and phosphates, as well as sodium chlorate, chloride, chlorite, and hypochlorite. This division’s products are used in chemical industry, derivatives manufacturing, swimming pools, compound fodder, paper pulp bleaching, and water treatment applications. Its Plastics division provides dichloroethane, vinyl chloride monomer, vinyl polychloride (VCM), and polyvinyl chloride (PVC) compounds for use in VCM and PVC manufacturing and construction applications. The company’s Intermediate Chemicals division offers formaldehyde, glues and resins, moulding compounds, paraformaldehyde, pentaerythritol, and sodium formate, which are used in derivatives manufacturing, wood industry, electrotechnics, resins, paints, and tanning industry applications. Its Pharmaceuticals division focuses on the production of raw materials and intermediary pharmaceutical products of antibiotics, hypercholesterolemia, anti-ulcer, and anti-fungal products. This division offers erythromycins, fusidic acid, and fosfomycins for use in antibiotic and skin infections. The company also exports its product to approximately 128 countries. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Founded in 1817

ercros sa (ECR) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

ercros sa (ECR) Key Developments

Ercros, S.A. Reports Financial Results for the Year 2014; Provides Financial Outlook for 2015

Ercros, S.A. reported financial results for the year 2014. For the year, total income was EUR 606.80 million against EUR 624.21 million for the last year. Ebitda was EUR 14.44 million against EUR 28.45 million for the last year. LBIT was EUR 5.01 million against EUR 9.14 million for the last year. Loss before tax was EUR 12.51 million against EUR 1.00 million for the last year. Loss for the year was EUR 6.29 million against EUR 3.75 million for the last year. In 2014, the turnover of Ercros amounted to EUR 603.67 million, 3.4% lower than that achieved in 2013. The main reason behind this decline is the lower price for caustic soda and PVC, in line with the observed downward trend in commodities prices. The turnover for the fourth quarter was also affected by a substantial cut in the compensation received for the interruptibility services provided by the company to the electricity system operator and by a lower production in some plants due to the force majeure declared by one of the leading suppliers and to scheduled maintenance activities. Non-recurrent items have amounted to EUR 4.93 million against EUR 0.57 million in 2013, while ebitda linked to the ordinary activities of the company has reached EUR 19.37 million compared to EUR 27.88 million in the previous year. The financial loss has amounted to EUR 7.50 million, compared to EUR 10.14 million in the previous year, as a result of interest rates reduction and less indebtedness. As at December 31, 2014, the net financial debt stood at EUR 99.52 million, EUR 24.32 million less than in 2013 after the repayment of most of the financial debt with suppliers and other financing facilities. To calculate the net financial debt, the company has deducted all the deposits used as collateral of debts. Ercros considers that what has happened in the fourth quarter of 2014 has been due to extraordinary events mostly beyond the control of the company, which need not be repeated. For the outlook of 2015, the company announced that it is much more promising as a result of the continuing recovery of the economic activity already seen in 2014. There are several facts that give support to the expected improvement of the results: the strengthening of the dollar against the euro, which is already having a significant impact on the overall activity of the company in the first months of the year and, especially in export oriented businesses, such as intermediate chemicals and pharmaceuticals, and the dramatic reduction in oil prices, which impact the price of natural gas. On the other side, it should note the risk of higher electricity prices fixed by the market in daily auctions, and the lower compensation for the interruptibility services.

Ercros, S.A. Reports Earnings Results for the Third Quarter Ended September 30, 2014

Ercros, S.A. reported earnings results for the third quarter ended September 30, 2014. For the quarter, the company reported that profit for the third quarter ended September 30, 2014 was EUR 2.88 million, compared to a loss of EUR 3.66 million for the same quarter ended September 30, 2013. EBITDA for the third quarter was EUR 21.86 million, compared to EUR 20.08 million for the same quarter ended September 30, 2013. EBIT was EUR 7.84 million, compared to EUR 5.39 million for the same quarter ended September 30, 2013. Profit before tax was EUR 2.89 million, compared to a loss before tax of EUR 3.68 million for the same quarter ended September 30, 2013.

Ercros, S.A. Announces Consolidated Earnings Results for the Nine Months Ended September 30, 2014

Ercros, S.A. announced consolidated earnings results for the nine months ended September 30, 2014. For the period, the company reported income of €465.07 million compared with €482.26 million for the same period a year ago. Ebitda was €21.86 million compared with €20.08 million for the same period a year ago. Ebit was €7.84 million compared with €5.39 million for the same period a year ago. Profit before tax was €2.89 million compared with loss before tax of €3.68 million for the same period a year ago. Profit for the period was €2.88 million compared with loss for the period of €3.66 million for the same period a year ago. Net financial debt was €115.42 million compared with €133.65 million for the period ended December 31, 2013. The company profits in the first nine months of 2014 have risen to €2.88 million, up by €6.54 million on the loss of €3.66 million incurred in the same period of the previous year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ECR:SM €0.48 EUR +0.018

ECR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ECR.
View Industry Companies

Industry Analysis


Industry Average

Valuation ECR Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ERCROS SA, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at